Risk assessment for coenzyme Q10 (Ubiquinone). (Q34543557)

2 August 2017

1 reference

title

Risk assessment for coenzyme Q10 (Ubiquinone). (English)

1 reference

2 August 2017

0 references

John N Hathcock

1

1 reference

2 August 2017

Andrew Shao

series ordinal

2

1 reference

2 August 2017

language of work or name

English

0 references

publication date

30 June 2006

1 reference

Regulatory Toxicology and Pharmacology

2 August 2017

published in

1 reference

2 August 2017

volume

45

1 reference

2 August 2017

issue

3

1 reference

2 August 2017

page(s)

282-288

1 reference

The effect of coenzyme Q10 on blood glucose and insulin requirement in patients with insulin dependent diabetes mellitus

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

Italian multicenter study on the safety and efficacy of coenzyme Q10 as adjunctive therapy in heart failure. CoQ10 Drug Surveillance Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

Coenzyme Q(10) supplementation in infertile men with idiopathic asthenozoospermia: an open, uncontrolled pilot study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

Exogenous CoQ10 preserves plasma ubiquinone levels in patients treated with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

Therapeutic effects of coenzyme Q10 in neurodegenerative diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

Randomized, double-blind, placebo-controlled trial of coenzyme Q10 in isolated systolic hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

Protection by coenzyme Q10 from myocardial reperfusion injury during coronary artery bypass grafting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

Coenzyme Q10 and diabetic endotheliopathy: oxidative stress and the 'recoupling hypothesis'.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

Treatment for mitochondrial disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

Vitamins, supplements, herbal medicines, and arrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

Coenzyme Q10 combined with mild hypothermia after cardiac arrest: a preliminary study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

Assessment of coenzyme Q10 tolerability in Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

Tolerance of high-dose (3,000 mg/day) coenzyme Q10 in ALS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

Coenzyme Q10 increases T4/T8 ratios of lymphocytes in ordinary subjects and relevance to patients having the aids related complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

The activities of coenzyme Q10 and vitamin B6 for immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

Two successful double-blind trials with coenzyme Q10 (vitamin Q10) on muscular dystrophies and neurogenic atrophies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

Biochemical rationale and the cardiac response of patients with muscle disease to therapy with coenzyme Q10.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

Clinical improvement after administration of coenzyme Q10 in a patient with mitochondrial encephalomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

Impact of ubiquinone (coenzyme Q10) treatment on glycaemic control, insulin requirement and well-being in patients with Type 1 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

Can coenzyme Q10 improve vascular function and blood pressure? Potential for effective therapeutic reduction in vascular oxidative stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

Coenzyme Q10 improves blood pressure and glycaemic control: a controlled trial in subjects with type 2 diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

Coenzyme Q10 as an adjunctive in the treatment of chronic congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

Safety assessment of coenzyme Q10 (Kaneka Q10) in healthy subjects: a double-blind, randomized, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

Effects of coenzyme Q10 on exercise tolerance in chronic stable angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

The effect of coenzyme Q10 in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

Energy metabolism defects in Huntington's disease and effects of coenzyme Q10.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

Ubiquinone supplementation and exercise capacity in trained young and older men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

Usefulness of coenzyme Q10 in clinical cardiology: a long-term study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

Response of patients in classes III and IV of cardiomyopathy to therapy in a blind and crossover trial with coenzyme Q10.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

Clinical aspects of coenzyme Q10: an update.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

Partial and complete regression of breast cancer in patients in relation to dosage of coenzyme Q10

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

Progress on Therapy of Breast Cancer with Vitamin Q10 and the Regression of Metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

The effect of ascorbate and ubiquinone supplementation on plasma and CSF total antioxidant capacity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

Effects of ubiquinone-10 supplementation and high intensity training on physical performance in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

Therapy with Coenzyme Q10 for Patients with Periodontal Disease. 1. Effect of Coenzyme Q10 on Subgingival Microorganisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

Possible molecular mechanisms of the protonmotive function of cytochrome systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

Effects of oral supplementation of coenzyme Q10 on 31P-NMR detected skeletal muscle energy metabolism in middle-aged post-polio subjects and normal volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

Mitochondria as target for antiischemic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

Familial cerebellar ataxia with muscle coenzyme Q10 deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

Primary coenzyme Q10 deficiency and the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

Coenzyme Q10 in plasma and erythrocytes: comparison of antioxidant levels in healthy probands after oral supplementation and in patients suffering from sickle cell anemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

The biochemical, pathophysiological, and medical aspects of ubiquinone function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

Ubiquinone (coenzyme Q10) in the long-term treatment of idiopathic dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

The effect of oral coenzyme Q10 on the exercise tolerance of middle-aged, untrained men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

Coenzyme Q10 therapy before cardiac surgery improves mitochondrial function and in vitro contractility of myocardial tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

The effects of ageing on the response to cardiac surgery: protective strategies for the ageing myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

Coenzyme Q10 protects the aging heart against stress: studies in rats, human tissues, and patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

Open label trial of coenzyme Q10 as a migraine preventive.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

Dietary coenzyme Q10 supplementation alters platelet size and inhibits human vitronectin (CD51/CD61) receptor expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

Coenzyme Q10 in neurodegenerative diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

Absorption, tolerability, and effects on mitochondrial activity of oral coenzyme Q 10 in parkinsonian patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

A possible role of coenzyme Q10 in the etiology and treatment of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

Effect of coenzyme Q10 on risk of atherosclerosis in patients with recent myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

Randomized, double-blind placebo-controlled trial of coenzyme Q10 in patients with acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

The effects of coenzyme Q10 treatment on maternally inherited diabetes mellitus and deafness, and mitochondrial DNA 3243 (A to G) mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

Coenzyme Q(10) improves endothelial dysfunction of the brachial artery in Type II diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2006.05.006

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YRTPH.2006.05.006

1 reference

2 August 2017

1 reference